Screening of viral specific T-cell lines for HLA alloreactivity prior to adoptive immunotherapy may prevent GvHD
- 15 April 2011
- journal article
- editorial
- Published by Elsevier in Transplant Immunology
- Vol. 24 (3) , 141
- https://doi.org/10.1016/j.trim.2010.12.001
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Alloreactivity from human viral specific memory T-cellsTransplant Immunology, 2010
- Allo-HLA reactivity of virus-specific memory T cells is commonBlood, 2010
- T Cell Allorecognition via Molecular MimicryImmunity, 2009
- New tools to monitor the impact of viral infection on the alloreactive T‐cell repertoireTissue Antigens, 2009
- Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognitionBlood, 2009
- EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic ResponsesThe Journal of Immunology, 2006
- CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULESTransplantation, 2004
- Herpes simplex virus type 2–specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I allelesBlood, 2002
- An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.The Journal of Experimental Medicine, 1994
- HLA‐DR‐4‐associated alloreactivity of an HLA‐DR‐3‐ restricted human tetanus toxoid‐specific T cell clone: inhibition of both reactivities by an alloantiserumEuropean Journal of Immunology, 1985